Jonathan Nolasco

Jonathan Nolasco is a seasoned scientist with extensive expertise in formulation and drug delivery, currently serving as a Senior Scientist in Non Viral Delivery at Novo Nordisk since November 2023. Prior experience includes positions as Senior Scientist at Omega Therapeutics, where focus was on formulation and drug delivery, and as Scientist at Sanofi, concentrating on biologics design and generation. Jonathan has also worked at Seqirus in various capacities related to formulation and delivery, and conducted master's research at Harvard Medical School, exploring proteasome population dynamics and MHC-I peptide generation. Academic qualifications include a Master's degree in Biology from Harvard University and a Bachelor of Science in Microbial Biology from the University of California, Berkeley.